Pancreatic Cancer



Pancreatic cancer is the second most common gastrointestinal malignancy and the fourth most common cause of cancer related deaths in the United States. The incidence of pancreatic cancer increases after age 45, making it a significant problem in the geriatric population. Risk factors for pancreatic cancer include chronic pancreatitis, cigarette smoking, diabetes mellitus, and diet. Most patients are diagnosed after they become symptomatic with abdominal pain, jaundice, or weight loss. Surgery remains the mainstay of treatment, but fewer than 20% of cases are resectable at presentation. Chemoradiation is an adjunct to surgery mainly for palliation of metastases. Even in those resectable, the median survival is a dismal 18 months. Besides the need for advances in therapeutic modalities, defining a high risk, asymptomatic population for screening remains a challenge.


Pancreatic Cancer Acute Pancreatitis Intraductal Papillary Mucinous Neoplasm Islet Cell Tumor Gastric Outlet Obstruction 


  1. 1.
    American Cancer Society. Cancer facts & figures 2009. Atlanta: American Cancer Society; 2009.Google Scholar
  2. 2.
    Altekruse SF, Kosary CL, Krapcho M, Neyman N, Aminou R, Waldron W, Ruhl J, Howlader N, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Cronin K, Chen HS, Feuer EJ, Stinchcomb DG, Edwards BK. SEER cancer statistics review, 1975-2007. Bethesda, MD: National Cancer Institute; 2009.Google Scholar
  3. 3.
    Flook R, van Zanten SV. Pancreatic cancer in Canada: incidence and mortality trends from 1992-2005. Can J Gastroenterol. 2009;23(8):546–50.PubMedGoogle Scholar
  4. 4.
    Klein AP, Hruban RH, Brune KA, et al. Familial pancreatic cancer. Cancer J. 2001;7:266–73.PubMedGoogle Scholar
  5. 5.
    Amundadottir L, Kraft P, Stolzenberg-Solomon RZ, et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet. 2009;41:986–90.PubMedCrossRefGoogle Scholar
  6. 6.
    Lynch SM, Vrieling A, Lubin JH, et al. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Am J Epidemiol. 2009;170:403–13.PubMedCrossRefGoogle Scholar
  7. 7.
    Nothlings U, Wilkens LR, Murphy SP, et al. Meat and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study. J Natl Cancer Inst. 2005;97:1458–65.PubMedCrossRefGoogle Scholar
  8. 8.
    Zhang J, Dhakal IB, Gross MD, et al. Physical activity, diet and pancreatic cancer: a population based, case control study in Minnesota. Nutr Cancer. 2009;61(4):457–65.PubMedCrossRefGoogle Scholar
  9. 9.
    Everhart J, Wright D. Diabetes mellitus as a risk factor for pancreatic cancer. A meta-analysis. JAMA. 1995;273(20):1605–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Pannala R, Leirness JB, Bamlet WR, et al. Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroente­rology. 2008;134:981–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Raimondi S, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol. 2009;6(12):699–708.PubMedCrossRefGoogle Scholar
  12. 12.
    Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17–32.PubMedCrossRefGoogle Scholar
  13. 13.
    Zhang Y, Coogan PF, Palmer JR, et al. A case-control study of reproductive factors, female hormone use and risk of pancreatic cancer. Cancer Causes Control. 2010;21(3):473–8.PubMedCrossRefGoogle Scholar
  14. 14.
    Li D, Morris JS, Liu J, Hassan MM, et al. Body mass index and risk, age of onset and survival in patients with pancreatic cancer. JAMA. 2009;301(24):2553–62.PubMedCrossRefGoogle Scholar
  15. 15.
    Hruban RH, Pitman MB, Klimstra DS, editors. Ductal adenocarcinoma. In: AFIP atlas of tumor pathology. Tumors of the pancreas, Washington, DC: American Registry of Pathology; 2007. pp 111–64.Google Scholar
  16. 16.
    Li D, Xie K, Wolff R, et al. Pancreatic cancer. Lancet. 2004;363:1049–57.PubMedCrossRefGoogle Scholar
  17. 17.
    Holly EA, Chaliha I, Bracci PM, Gautam M. Signs and symptoms of pancreatic cancer: a population-based case-control study in the San Francisco Bay area. Clin Gastroenterol Hepatol. 2004;2:510–7.PubMedCrossRefGoogle Scholar
  18. 18.
    Mujica VR, Barkin JS, Go VL. Acute pancreatitis secondary to pancreatic carcinoma. Study group participants. Pancreas. 2000;21:329–32.PubMedCrossRefGoogle Scholar
  19. 19.
    Sachs T, Pratt WB, Callery MP, Vollmer Jr CM. The incidental asymptomatic pancreatic lesion: nuisance or threat? J Gastrointest Surg. 2009;13(3):405–15.PubMedCrossRefGoogle Scholar
  20. 20.
    Goonetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol. 2007;33(3):266–70.PubMedCrossRefGoogle Scholar
  21. 21.
    Soriano A, Castells A, Ayuso C, et al. Preoperative staging and tumor resectability assessment of pancreatic cancer: prospective study comparing endoscopic ultrasonography, helical computed tomography, magnetic resonance imaging, and angiography. Am J Gastroenterol. 2004;99:492–501.PubMedCrossRefGoogle Scholar
  22. 22.
    DeWitt J, Devereaux B, Chriswell M, et al. Comparison of endoscopic ultrasonography and multidetector computed tomography for detecting and staging pancreatic cancer. Ann Intern Med. 2004;141:753–63.PubMedGoogle Scholar
  23. 23.
    Bilimoria KY, Bentrem DJ, Ko CY, et al. National failure to operate on early stage pancreatic cancer. Ann Surg. 2007;246:173–80.PubMedCrossRefGoogle Scholar
  24. 24.
    Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality. Ann Surg. 2002;236:355–66.PubMedCrossRefGoogle Scholar
  25. 25.
    Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200–10.PubMedCrossRefGoogle Scholar
  26. 26.
    Small Jr W, Berlin J, Freedman GM, et al. Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial. J Clin Oncol. 2008;26:942–7.PubMedCrossRefGoogle Scholar
  27. 27.
    Schmidt CM, Powell ES, Yiannoutsos CT, et al. Pancreaticoduode­nectomy: a 20-year experience in 516 patients. Arch Surg. 2004;139:718–25.PubMedCrossRefGoogle Scholar
  28. 28.
    Pratt WB, Gangavati A, Agarwal K, et al. Establishing standards of quality for elderly patients undergoing pancreatic resection. Arch Surg. 2009;144(10):950–6.PubMedCrossRefGoogle Scholar
  29. 29.
    Joergensen MT, Brusgaard K, Crüger DG, Gerdes AM, Schaffalitzky de Muckadell OB. Genetic, epidemiological, and clinical aspects of hereditary pancreatitis: a population-based cohort study in Denmark. Am J Gastroenterol. 2010;105(8):1876–83.PubMedCrossRefGoogle Scholar
  30. 30.
    Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology. 2000;119:1447–53.PubMedCrossRefGoogle Scholar
  31. 31.
    Hahn SA, Greenhalf B, Ellis I, et al. BRCA2 germline mutations in familial pancreatic carcinoma. J Natl Cancer Inst. 2003;95:214.PubMedCrossRefGoogle Scholar
  32. 32.
    Callery MP, Chang KJ, Fishman EK, et al. Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement. Ann Surg Oncol. 2009;16:1727.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of Medicine, Division of Gastroenterology and HepatologyMayo ClinicRochesterUSA

Personalised recommendations